Giulia Unali, PhD
Postdoctoral Associate
Boston University Chobanian & Avedisian School of Medicine
Virology, Immunology & Microbiology



Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Valeri E, Unali G, Piras F, Abou-Alezz M, Pais G, Benedicenti F, Lidonnici MR, Cuccovillo I, Castiglioni I, Arévalo S, Spinozzi G, Merelli I, Behrendt R, Oo A, Kim B, Landau NR, Ferrari G, Montini E, Kajaste-Rudnitski A. Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells. Mol Ther. 2024 Jan 03; 32(1):124-139. PMID: 37990494; PMCID: PMC10787167; DOI: 10.1016/j.ymthe.2023.11.020;
     
  2. Unali G, Crivicich G, Pagani I, Abou-Alezz M, Folchini F, Valeri E, Matafora V, Reisz JA, Giordano AMS, Cuccovillo I, Butta GM, Donnici L, D'Alessandro A, De Francesco R, Manganaro L, Cittaro D, Merelli I, Petrillo C, Bachi A, Vicenzi E, Kajaste-Rudnitski A. Interferon-inducible phospholipids govern IFITM3-dependent endosomal antiviral immunity. EMBO J. 2023 May 15; 42(10):e112234. PMID: 36970857; PMCID: PMC10183820; DOI: 10.15252/embj.2022112234;
     
  3. Unali G, Crivicich G, Pagani I, Abou-Alezz M, Folchini F, Valeri E, Matafora V, Reisz JA, Giordano AMS, Cuccovillo I, Butta GM, Donnici L, D'Alessandro A, De Francesco R, Manganaro L, Cittaro D, Merelli I, Petrillo C, Bachi A, Vicenzi E, Kajaste-Rudnitski A. Interferon-inducible phospholipids govern IFITM3-dependent endosomal antiviral immunity. EMBO J. 2023 Mar 27; e112234. PMID: 36970857; PMCID: PMC10183820; DOI: 10.15252/embj.2022112234;
     
  4. Ferrari S, Jacob A, Cesana D, Laugel M, Beretta S, Varesi A, Unali G, Conti A, Canarutto D, Albano L, Calabria A, Vavassori V, Cipriani C, Castiello MC, Esposito S, Brombin C, Cugnata F, Adjali O, Ayuso E, Merelli I, Villa A, Di Micco R, Kajaste-Rudnitski A, Montini E, Penaud-Budloo M, Naldini L. Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells. Cell Stem Cell. 2022 Oct 06; 29(10):1428-1444.e9. PMID: 36206730; PMCID: PMC9550218; DOI: 10.1016/j.stem.2022.09.001;
     
  5. Soldi M, Sergi Sergi L, Unali G, Kerzel T, Cuccovillo I, Capasso P, Annoni A, Biffi M, Rancoita PMV, Cantore A, Lombardo A, Naldini L, Squadrito ML, Kajaste-Rudnitski A. Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering. Mol Ther Methods Clin Dev. 2020 Dec 11; 19:411-425. PMID: 33294490; PMCID: PMC7683235; DOI: 10.1016/j.omtm.2020.10.009;
     
  6. Ferrari S, Jacob A, Beretta S, Unali G, Albano L, Vavassori V, Cittaro D, Lazarevic D, Brombin C, Cugnata F, Kajaste-Rudnitski A, Merelli I, Genovese P, Naldini L. Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking. Nat Biotechnol. 2020 11; 38(11):1298-1308. PMID: 32601433; PMCID: PMC7610558; DOI: 10.1038/s41587-020-0551-y;
     
  7. Petrillo C, Thorne LG, Unali G, Schiroli G, Giordano AMS, Piras F, Cuccovillo I, Petit SJ, Ahsan F, Noursadeghi M, Clare S, Genovese P, Gentner B, Naldini L, Towers GJ, Kajaste-Rudnitski A. Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells. Cell Stem Cell. 2018 12 06; 23(6):820-832.e9. PMID: 30416070; PMCID: PMC6292841; DOI: 10.1016/j.stem.2018.10.008;
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 6 publications over 4 distinct years, with a maximum of 2 publications in 2020 and 2023

YearPublications
20181
20202
20221
20232

Contact for Mentoring:

Unali's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Similar People
_
Same Department